Morning Briefing
Summaries of health policy coverage from major news organizations
CDC Reviewing Safety Of Pfizer Bivalent Booster For Seniors; Still Recommends Shot
The Centers for Disease Control and Prevention on Friday said it is 鈥渧ery unlikely鈥 the Pfizer omicron booster carries a risk of stroke for seniors after it launched an investigation into a preliminary safety concern detected by one of its monitoring systems. (Kimball, 1/13)
The Centers for Disease Control and Prevention (CDC) says that a preliminary COVID-19 vaccine "safety signal" has been identified and is investigating whether the Bivalent Pfizer-BioNTech vaccine creates an increased risk of ischemic stroke in people 65 and older. In the Friday statement, the CDC said that the preliminary signal hasn't been identified with the Bivalent Moderna COVID-19 vaccine. (Sabes, 1/13)
The potential risk with Pfizer鈥檚 vaccine was not seen in other safety databases, nor was it seen with Moderna Inc.鈥檚 Covid vaccine, the officials said in a statement on the Food and Drug Administration鈥檚 website. The early finding still needs more investigation, and recommendations for the vaccine have not been changed, the statement said.聽(Langreth and Rutherford, 1/13)
In related news about vaccines and covid treatments 鈥
Pfizer鈥檚 new COVID-19 booster ad starring Martha Stewart is both rather odd and strangely聽compelling to watch in a definitive departure from its previous conservative vaccine commercials.聽The 30-second聽spot,聽鈥淯nwelcome Guest,鈥 features Stewart in her beautifully perfect kitchen calmly sharpening a massive Samurai sword. (Coey, 1/13)
The antidepressant fluvoxamine doesn't shorten the duration of COVID-19 symptoms in mildly to moderately ill adults, according to a randomized clinical trial (RCT) published yesterday in JAMA. (Van Beusekom, 1/13)
A Mayo Clinic鈥搇ed meta-analysis suggests that transfusion of COVID-19 convalescent plasma improves survival in hospitalized, infected patients who have impaired immune systems. The antibody-rich plasma, donated by COVID-19 survivors, may help prevent the reinfections to which these high-risk patients are susceptible, the researchers said. The study was published yesterday in JAMA Network Open. (Van Beusekom, 1/13)